Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

SUMMARY: Vertebral fractures are a major adverse consequence of osteoporosis. In a large placebo-controlled trial in postmenopausal women with osteoporosis, strontium ranelate reduced vertebral fracture risk by 33% over 4 years, confirming the role of strontium ranelate as an effective long-term tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Meunier, P. J., Roux, C., Ortolani, S., Diaz-Curiel, M., Compston, J., Marquis, P., Cormier, C., Isaia, G., Badurski, J., Wark, J. D., Collette, J., Reginster, J. Y.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744775/
https://www.ncbi.nlm.nih.gov/pubmed/19153678
http://dx.doi.org/10.1007/s00198-008-0825-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744775/
https://www.ncbi.nlm.nih.gov/pubmed/19153678
http://dx.doi.org/10.1007/s00198-008-0825-6

Ejemplares similares